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GENUS applications for Alzheimer’s Disease Pathology
Abstract[1]
Estimates vary, but it is thought that 5.5 million Americans age 60 and up may be 
living with Alzheimer’s diseases (AD). AD is the most common type of dementia and is 
characterized by a decline in episodic memories, long-term memory, language, attention, 
and personality changes. The first symptoms can vary, but for most people memory is the 
first capacity to become impaired. However, symptoms can also be a decline in non-
memory aspects of cognition like work-finding, vision/spatial issues, and impaired 
reasoning or judgement. AD is identified mainly by two histopathological features: 
extracellular plague of amyloid-beta protein and intracellular neuronal tangles formed by 
abnormally phosphorylated tau protein. The damage begins to take place in the 
hippocampus and entorhinal cortex, which are both parts of the brain essential for 
memory processing.
As neurons die, brain tissue is affected and begins to shrink. Patient with AD show 
changes in brain waves which are composed of electrical impulses from masses of 
neurons that communicate with each other. There are also findings of microglia gathering 
around the amyloid-beta plaque deposits in patients with AD as well. Microglia are 
thought to have many roles in the brain but cleaning up debris is the most important. 
These findings have led researchers into exploring more options by altering brain waves 
and triggering cellular responses in the brain. Recent research using AD mouse models 
suggest that non-invasive brain stimulation could offer potential future interventions for 
people suffering from neurodegenerative diseases. 
Analysis of Visual GENUS Results [3]
• The researchers first performed testing by using a custom-made 
LED device to deliver visual stimuli at specific frequencies. This 
was to determine whether 40Hz of visual stimulation could 
modulate neuronal activity beyond the primary visual cortex 
(V1) by using c-FOS immunostaining as a marker of neuronal 




• 40Hz visual stimulation increased the number of c-Fos+ cells in 
V1 (Figures 1A, 1B, S1A, and S1B) as well as in somatosensory 
cortex (SS1), hippocampal area (CA1) and dentate gyrus (DG), 
and cingulate cortex ( CC) of the prefrontal cortex (PFC) 
(Figures 1B, S1A, and S1B) Results show that GENUS could 
recruit high-orders of brain functions. 
Figure S1B.
Understanding that GENUS could interfere with high-orders of brain functions, they tested to see 
whether GENUS could impact neurodegeneration in AD mouse models. They tested the effects of 
GENUS used on P301S mouse models which showed synaptic and neuronal loss and cognitive deficits 
by 8 months of age. Before testing the potential of GENUS, they first wanted to confirm that 40Hz of 
stimulation could entrain neural oscillations even in conditions of neurodegeneration. 
• Found significant enhanced LFP gamma power in 8-month-old P301S in response to 40Hz of 
stimulation in V1, CA1, and PFC (Figures 2A, S2A-S2C) compared to occluded light at 40Hz. 
To explore the potential for chronic GENUS to impact neurodegeneration first, subjected a cohort of 
P3O1S to either no stimulation (No Stim) or GENUS 1h/day for 22 days, starting at 7.5 months (time 
point when neuronal loss begins) and assessed neurodegeneration at 8 months of age (Figure 2B)
• Immunohistochemical (IHC) analysis with the neuronal marker 
(NeuN)  confirmed that No Stim P301S have reduced NeuN+ 
cells in V1 and CA1 (figure 2B and 2C). In contrast, the number 
of NeuN+ cells in GENUS P310S did not differ from the WT 
mice in V1 and CA1 (Figures 2B,2C,S2D)
• Obtained similar results using fluorescence-acitivated cell sorting 
(FACS) to isolate and quantify NeuN+ nuclei-→ No Stim 
showed a significant reduction in NeuN+ nuclei in V1, whereas 
GENUS P301S did not differ from WT controls (figure S2E)
Introduction [2,3,4]
Alzheimer’s disease is characterized as a decline in cognitive function and loss of 
brain tissue, and it is the most common type of dementia. The pathology of Alzheimer’s 
disease can be contributed to the amyloid-beta deposition and tau protein accumulation. 
These pathological changes trigger cellular mediated responses and patients with AD 
show a reduction in power of gamma frequency oscillation. It is already found that 
gamma oscillations, which can range from 30-120Hz, are responsible for cognitive 
function, learning, memory and information processing. However, during the progression 
of AD these gamma oscillations have shown decrease in the power of gamma 
oscillations, which have been found to range anyway where from 25-80Hz. 
Two studies conducted in 2019, set out to show how using visual and auditory 
gamma entrainment neural stimulation (GENUS) could offer a promising alternative way 
to help slow the progression of AD. Both studies used multiple AD mouse models that 
underwent different sensory testing and comparative analysis to understand the effects of 
GENUS and learn the potential benefits. Below is a graphical diagram from both articles 
representing the overall experimental set-up of which the mice received the stimulus.
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Analysis of Auditory GENUS Results [4]
In this study, based off the findings found in the Visual GENUS, researchers wanted to test the 
effect of Auditory GENUS on AD mouse models. 
They investigated the effects that auditory GENUS could play in reducing amyloid build-up in 
the auditory cortex (AC) and hippocampus (HPC)  of 5XFAD mice. Mice were given either no 
stimulation, 40Hz, 8Hz, 80HZ, or random stimulation to also determine whether GENUS is 
specific for 40Hz
• Under the 40Hz of stimulation, reduced levels of soluble amyloid were seen in the AC of 
GENUS 5XFAD mice compared to no stimulation given. 
• Additionally, there was reduced levels on insoluble amyloid seen in both AC and HPC in 
GENUS 5XFAD mice compared to the no stimulation controls. (Figures 3A, S3A, and 3B). 
• Amyloid reduction was specific to 40 Hz stimulation, as neither 8 Hz, 80Hz, nor random 
frequency stimulation significantly changed Aβ levels, versus no stimulation controls. 
• After understanding that auditory GENUS can reduce amyloid loads, they decided to test 
the in older 5XFAD mice. They examined plaque load in 6-month-old 5XFAD mice after 
auditory GENUS versus no stimulation controls. 
Next, the research team carried out similar analysis in another AD model, 9-month-old APP/PS1 
mice (6-month-old APP/PS1 mice do not have significant plaque load). Their results showed 
consistent findings in 5XFAD mice compared to the APP/PS1 mice which was a significant 
reduction in plaque numbers after auditory GENUS. Immunostaining for amyloid levels also 
showed significant reductions (Figures S3C-S3E)
Collectively, these results help demonstrate that auditory GENUS can reduce amyloid load in 
areas outside of the primary sensory cortices in multiple AD mouse models. 
After establishing the effect of auditory GENUS on multiple AD mouse models, they wanted to 
understand the connection between auditory GENUS and cellular-mediated responses. Evidence 
from previous research has already confirmed that microglia are responsive to changes in 
neuronal activity and play a role in AD. The team wanted to experiment the effects that auditory 
GENUS had on glia and blood vessel responses in 5XFAD mice. 
After exploring how auditory GENUS affects microglia responses, the team wanted to apply this 
knowledge and test whether GENUS influenced astrocyte function/responses. One of the many 
roles of astrocytes is to regulate the brain’s vascular network, which have been shown in other 
research to play a role in amyloid clearance from the brain. 
• First, they immunostained for tomato lectin, a marker of vascular endothelium, to assess 
vasodilation (Figures 5A and 5B) and observed increased blood vessel diameter after auditory 
GENUS versus no stimulation controls (Figure 5C). 
• Amyloid transcytosis through the brain endothelium is mediated by lipoprotein receptor-
related protein 1 (LRP1). Thus, they co-immunostained for amyloid with LRP1 (Figures 5D 




• Immunostaining with a β-amyloid 
specific antibody D54D2 revealed 
significantly reduced plaque 
numbers and size after auditory 
GENUS (Figures 3C and 3D on 
the left) 
Figure S3C. Figures S3D and S3E. 
• Results using immunostaining for the 
microglia marker Iba1 in the AC and CA1 
of a 6-month- old 5XFAD mice showed 
about ~60% increased in microglia 
presence in both the AC and CA1 after 
auditory GENUS vs no stimulation 




Figure 4D. Figure 4E and 4F. 
• The cell bodies and arborization had shown 
in increase in microglia in both areas 
suggesting that auditory GENUS has an 
influence on glia responses. (Figures 4D-F) 
Together, these results suggest auditory 
GENUS may elicit increased clearance of 
Aβ through microglia and changes in the 
vasculature.
Figure 5A and 5B. 




Overall, both studies showed how sensory stimulation can modulate brain waves and help 
induce cellular-mediated responses to help reduce pathologies that contribute to AD. In the 
visual GENUS study, they aimed to test the effects of neural stimulation on gamma brain 
waves, which are responsible for higher cognitive function.  They offered evidence that 
suggest that not only can visual GENUS modulate gamma brain waves, but it can also 
increase their function and could possibly lead to an alternative treatment for AD.
Once they understood the effects of visual GENUS on gamma brain waves, they explored 
whether visual GENUS could reduce pathologies related to neurodegeneration in AD mouse 
models. Their results showed that AD mouse model subjected to GENUS showed similar 
number of cells as compared to the wild-type mouse models, but when compared to AD 
mouse model that received no stimulation, they showed a reduction in cells. Suggesting that 
GENUS could offer a potential treatment to slow the progression of AD pathologies. 
The findings from the visual GENUS study were then applied to another study that utilized 
auditory GENUS instead to determine if other sensory stimuli can affect pathologies related 
to AD. They showed that auditory GENUS induces a microglia morphological response, 
indicative of increased Aβ-uptake, in primary sensory cortex as well as the hippocampus. 
Their results indicated that increase Aβ-uptake by microglia, vascular-dilation response, and 
potential amyloid transvascular transport showed an enhancement in Aβ clearance by 
auditory GENUS through multiple mechanisms. However, the experiments presented were 
performed in AD mouse models and future studies are essential into determine whether non-
invasive brain stimulation GENUS could be translatable to humans. 
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